SōlHaus founder’s personal journey leads to a start up… and opportunity to build communities.
A Journey to Wellness and a Startup August 3, 2018, was the final straw. Over the preceding year, Demetrius Glover’s Adderall prescription had lost its effectiveness. He became more depressed and more anxious. Worse, the suicidal thoughts were more common. The “final straw” was an extremely adverse reaction to what became his final dose of Adderall, a drug that treats attention deficit hyperactivity disorder (ADHD). Suddenly, Glover’s muscles stiffened, standing became difficult, and when he did stand he was unsteady. Add to that…